Immune thrombocytopenia (ITP) is a rare autoimmune disease that results in low platelet counts and an increased risk of spontaneous bleeding due to impaired blood clotting. Several therapeutic approaches can be used to treat patients with ITP. However, many patients either lose response in the long term or are unable to maintain a response after treatment discontinuation, necessitating chronic treatment and multiple lines of therapy. Here, two patients with ITP share their experience, each providing a firsthand description of their ITP diagnosis, symptoms, management, and perspectives on the future. These stories are complemented by a clinical review of ITP pathophysiology, symptoms, and treatments presented by two expert hematologists who care for patients with ITP. The physician perspective reinforces the challenges faced by patients in everyday life and highlights the remaining areas of concern regarding the treatment of chronic ITP.
Building similarity graph...
Analyzing shared references across papers
Loading...
Andrew Hsu
Tammy Fassett
Steve Pallagi
Advances in Therapy
University of Washington
Brown University
Fred Hutch Cancer Center
Building similarity graph...
Analyzing shared references across papers
Loading...
Hsu et al. (Tue,) studied this question.
www.synapsesocial.com/papers/69a75b2ec6e9836116a220cd — DOI: https://doi.org/10.1007/s12325-025-03438-7